Rosuvastatin Treatment Protects Against Nitrate-Induced Oxidative Stress

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2005-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/01.fjc.0000167010.98177.78PMID 16044029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.

  2004cited by this paper
• Antioxidant Effects of Statins via S-Nitrosylation and Activation of Thioredoxin in Endothelial Cells: A Novel Vasculoprotective Function of Statins

  2004cited by this paper
• Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012.

  2004cited by this paper
• Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.

  2004cited by this paper
• Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved?

  2004cited by this paper
• Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates.

  2004cited by this paper
• Prevention of Nitrate Tolerance by Long-Term Treatment with Statins

  2003cited by this paper
• Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.

  2003cited by this paper
• Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

  2003cited by this paper
• Identification of the enzymatic mechanism of nitroglycerin bioactivation

  2002cited by this paper
• Chronic Hydroxymethylglutaryl Coenzyme A Reductase Inhibition and Endothelial Function of the Normocholesterolemic Rat: Comparison With Angiotensin-Converting Enzyme Inhibition

  2002cited by this paper
• Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice.

  2002cited by this paper
• A Review of the Pharmacologic and Pharmacokinetic Aspects of Rosuvastatin

  2002cited by this paper
• Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase.

  2001cited by this paper
• Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits.

  2001cited by this paper
• Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance

  2001cited by this paper
• NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat

  2001cited by this paper
• Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans.

  2001cited by this paper
• Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

  2001cited by this paper
• Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis

  2000cited by this paper
• Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

  2000cited by this paper
• Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production.

  2000cited by this paper
• Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.

  2000cited by this paper
• A central role for the endothelial NADPH oxidase in atherosclerosis

  2000cited by this paper
• Endothelium-dependent responses in patients with hypercholesterolemic coronary artery disease under the effects of simvastatin and enalapril, either separately or combined.

  2000cited by this paper
• Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.

  2000cited by this paper
• Distinct and combined vascular effects of ACE blockade and HMG-CoA reductase inhibition in hypertensive subjects.

  1999cited by this paper
• Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS).

  1998cited by this paper
• Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells.

  1998cited by this paper
• Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.

  1998cited by this paper
• Neurohormonal Activation and Nitrate Tolerance: Implications for Concomitant Therapy With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers

  1998cited by this paper
• Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems*

  1998cited by this paper
• Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins: a bradykinin-dependent mechanism.

  1997cited by this paper
• Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin.

  1996cited by this paper
• Multiple‐dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG‐CoA reductase, in healthy subjects

  1996cited by this paper
• Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.

  1996cited by this paper
• Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.

  1995cited by this paper
• Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.

  1995cited by this paper
• Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.

  1994cited by this paper
• Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR).

  1980cited by this paper

• Effects of rosuvastatin on inducible nitric oxide synthase in rats with hyperlipidaemia and periodontitis

  2018cites this paper
• Anti-inflammatory effect of rosuvastatin decreases alveolar bone loss in experimental periodontitis.

  2017cites this paper
• Rosuvastatin and vascular oxidative stress induced by diesel exhaust particles

  2016cites this paper
• Effect of soluble guanylyl cyclase activator and stimulator therapy on nitroglycerin-induced nitrate tolerance in rats

  2015cites this paper
• Rosuvastatin ameliorates diabetes-induced reproductive damage via suppression of oxidative stress, inflammatory and apoptotic pathways in male rats.

  2015cites this paper
• Inhibition of NOX2 reduces locomotor impairment, inflammation, and oxidative stress after spinal cord injury

  2015cites this paper
• Possible effects of rosuvastatin on noise-induced oxidative stress in rat brain.

  2014cites this paper
• Beta-adrenoceptor antagonists and antianginal drugs

  2014cites this paper
• Chapter 7 – Pharmacologic Options for Treatment of Ischemic Disease

  2013cites this paper
• In vitro preventive effects of nitrate tolerance by a polyphenol-enriched extract of Hibiscus sabdariffa

  2013cites this paper
• Pleiotropic antioxidant potential of rosuvastatin in preventing cardiovascular disorders.

  2013cites this paper
• Vascular effects and antioxidant activity of two Combretum species from Democratic Republic of Congo.

  2012cites this paper
• Assessment of Endothelial Function in Humans and the Endothelial-protective Effects of 3-hydroxy-3-methylglutaryl coenzyme A Reductase Inhibitors

  2012influential citation
• Cardioprotective effects of rosuvastatin and carvedilol on delayed cardiotoxicity of doxorubicin in rats

  2012influential citation
• Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.

  2011cites this paper
• Rosuvastatin restored adrenergic and nitrergic function in mesenteric arteries from obese rats

  2011cites this paper
• The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients.

  2011cites this paper
• Organic nitrates and nitrate tolerance--state of the art and future developments.

  2010cites this paper
• The Antiplatelet Effects of Nitrates: Is it of Clinical Significance in Patients With Cardiovascular Disease?

  2010cites this paper
• Effects of Atorvastatin on Nitrate Tolerance in Diabetic Rats

  2010cites this paper
• Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1).

  2010cites this paper
• Oxidative stress produced by circulating microparticles in on-pump but not in off-pump coronary surgery

  2009cites this paper
• Myoglobin Induces Vascular Cell Adhesion Molecule-1 Expression through c-Src Kinase-Activator Protein-1/Nuclear Factor-ĸB Pathways

  2009cites this paper
• Demethylbellidifolin Prevents Nitroglycerin Tolerance via Improved Aldehyde Dehydrogenase 2 Activity

  2009cites this paper
• An Overview of the Extra-Lipid Effects of Rosuvastatin

  2008cites this paper
• Constitutive nitric oxide synthase activation is a significant route for nitroglycerin-mediated vasodilation

  2008cites this paper
• The enigma of nitroglycerin bioactivation and nitrate tolerance: news, views and troubles

  2008cites this paper
• Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

  2008cites this paper
• Chapter 5 – Pharmacologic Options for Treatment of Ischemic Disease

  2007cites this paper
• Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation.

  2007cites this paper
• Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats

  2007cites this paper
• Diabetes and vascular disease: From pathogenesis to treatment: Are vascular effects of hypoglycemic and hypolipidemic drugs independent of their metabolic effects?

  2007cites this paper
• EFECTO DE ROSUVASTATINA SOBRE LA EXPRESIÓN DE MOLÉCULA DE ADHESIÓN VASCULAR 1 EN CÉLULAS ENDOTELIALES HUMANAS ACTIVADAS POR SUERO DE PACIENTES CON SÍNDROME DE ANTICUERPOS ANTIFOSFOLÍPIDOS

  2007cites this paper
• Rosuvastatin treatment protects against nitrate‐induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway

  2006cites this paper
• Ramipril Treatment Protects Against Nitrate-induced Oxidative Stress in eNOS−/− Mice: An Implication of the NADPH Oxidase Pathway

  2006cites this paper